Pitt researchers to monitor resistance to HIV drugs in Africa

(University of Pittsburgh Schools of the Health Sciences) Infectious diseases researchers from the University of Pittsburgh School of Medicine are leading a five-year, $5 million initiative to monitor drug resistance during the rollout of HIV prevention drugs in sub-Saharan Africa.